Search Results - "Carpizo, D"

Predictors of Survival in Yttrium-90 Radioembolization of Hepatic Malignancies With Resin Microspheres by Newman, N.B, Ohman-Strickland, P.A, Carpizo, D, Benson, B, Gensure, R.H, Schonewolf, C.A, Moss, R.A, Melstrom, L, Nosher, J.L, Jabbour, S.K

Get full text

Dose-painted Intensity Modulated Radiation Therapy May Offer Improved Morbidity as Compared to 3D-CRT by Tunceroglu, A, Park, J, Poppe, M, Balasubramanian, S, Hernandez, D, Poplin, E, Carpizo, D, Gannon, C, Haffty, B.G, Jabbour, S.K

Get full text

Current management of cystic neoplasms of the pancreas by Carpizo, D.R, Allen, P.J, Brennan, M.F

“…Over the last decade there has been a dramatic increase in the number of patients identified with pancreatic cysts. This increase has been largely attributed…”
Get full text

Endogenous regulators of angiogenesis--emphasis on proteins with thrombospondin--type I motifs by Carpizo, D, Iruela-Arispe, M L

“…Angiogenesis has been acknowledged as an important requirement for growth and metastasis of tumors. Complete or partial suppression of vascular growth by a…”
Get full text

Minimally invasive pancreaticoduodenectomy - when less invasive does not result in fewer narcotic pills by Melucci, A., Lynch, O., Burchard, P., Schoeniger, L., Galka, E., Carpizo, D., Moalem, J., Linehan, D.

Get full text

Processing of VEGF-A by matrix metalloproteinases regulates bioavailability and vascular patterning in tumors by Lee, Sunyoung, Jilani, Shahla M, Nikolova, Ganka V, Carpizo, Darren, Iruela-Arispe, M. Luisa

“…Vascular endothelial growth factor (VEGF) is a critical mediator of blood vessel formation during development and in pathological conditions. In this study, we…”
Get full text

Abstract P6-20-05: Therapeutic targeting of BRCA1 and TP53 mutant breast cancer through mutant p53 reactivation by Yu, X, Wither, T, Gilleran, J, Yao, M, Foo, TK, Chen, C, Moore, D, Xia, B, Lin, Y, Kimball, D, Ganesan, S, Carpizo, D

“…Abstract Triple negative breast cancer (TNBC) is an aggressive subset for which novel therapeutic approaches are needed. A significant proportion of TNBC…”
Get full text

Early Postoperative ERAS Compliance is Associated with Decreased Length of Stay and Complications Following Liver Resection by Burchard, P., Dave, Y., Loria, A., Parikh, N., Pineda-Solis, K., Strawderman, M., Schoeniger, L., Galka, E., Tomiyama, K., Orloff, M., Carpizo, D., Linehan, D., Hernandez-Alejandro, R.

Get full text

Exploring the Paucity of the Diagnosis: Epithelioid Hemangioendothelioma of the Liver by Tsagkalidis, V., Casabianca, A., Burchard, P., Ullman, N., Melucci, A., Chacon, A., Reitz, A., Swift, D., Switchenko, J., Goyal, S., Carpizo, D., Shah, M.

Get full text

Should systemic therapy be standard of care for early-stage pancreatic acinar cell carcinoma? by Burchard, P., Ullman, N., Melucci, A., Chacon, A., Tsagkalidis, V., Casabianca, A., Reitz, A., Swift, D., Goyal, S., Switchenko, J., Maithel, S., Kooby, D., Carpizo, D., Shah, M.

Get full text

The precede consortium: A longitudinal international cohort study of individuals with a high-risk of pancreatic cancer by García García de Paredes, A., Katona, B., Zogopoulos, G., Brand, R., Kaul, V., Earl, J., Tempero, M., Kupfer, S., Paiella, S., Farrell, J., Sears, R., Sheppard, B., Grossberg, A., Idos, G., Chung, D., Golan, T., Friedman, E., Laish, I., Kwon, R., Stoffel, E., Merchant, N., Sussman, D., Brentnall, T., Gaddam, S., Jeter, J., Klute, K., Lowy, A., Liau, J., Lindberg, J., Permuth, J., Kastrinos, F., Bi, Y., Carpizo, D., Lin, J., Schrader, I., Lucas, A., Wadlow, R., Greenhalf, W., Shan, Y., Simeone, D.

Get full text

ADAMTS1: A Matrix Metalloprotease with Angioinhibitory Properties by IRUELA-ARISPE, M. LUISA, CARPIZO, DARREN, LUQUE, ALFONSO

“…: Neovascularization is a hallmark of cancer progression. Suppression of the angiogenic response in tumors has been associated with inhibition and even…”
Get full text

Acute acid exposure increases rabbit esophageal cell proliferation by Carpizo, Darren R., Reaka, Andrea J.H., Glaws, W.Reid, Pooley, Naomi, Schmidt, Larry, Halline, Allan G., Goldstein, Jay L., Layden, Thomas J.

“…In the present study we examined whether an acute infusion of HCI into the esophagus of rabbits would cause an increase in esophageal cellular proliferation…”
Get full text

Neoadjuvant therapy is associated with lower margin positivity rates after Pancreaticoduodenectomy in T1 and T2 pancreatic head cancers: An analysis of the National Cancer Database by Greco, Stephanie H., August, David A., Shah, Mihir M., Chen, Chunxia, Moore, Dirk F., Masanam, Monika, Turner, Amber L., Jabbour, Salma K., Javidian, Parisa, Grandhi, Miral S., Kennedy, Timothy J., Alexander, H. Richard, Carpizo, Darren R., Langan, Russell C.

“…Neoadjuvant therapy (NAT) for T1/T2 pancreatic adenocarcinoma (PDAC) prior to pancreaticoduodenectomy remains controversial. We compared positive margin rates…”
Get full text